MeSH tree: D20.215.894.899.085.125
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit worth potentially $125 ...
May 1, 2024
0
99
The global COVID-19 vaccination campaign saved an estimated 20 million lives. However, while current COVID-19 vaccines provide protection against developing severe disease, they do little to prevent infection and transmission.
Dec 14, 2023
0
129
When COVID-19 vaccines became obtainable in the United States, the policy of the Centers for Disease Control and Prevention was that individuals should receive the first available vaccine.
Mar 17, 2023
0
72
Regular physical activity may boost the effectiveness of the COVID-19 jab, with the level of protection afforded against serious infection rising in tandem with the amount of physical activity done, suggests research published ...
Oct 24, 2022
0
61
There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body's immune system attacks the nerves, according to a Rutgers-led study.
Oct 4, 2022
0
80
South Africa's medicines regulatory authority says it has recorded two fatal cases of the rare Guillain-Barre syndrome in people who had received a Johnson & Johnson COVID jab.
Sep 13, 2022
0
217
Adenoviral-based COVID-19 vaccines may be associated with increased incidence of myocardial infarction and pulmonary embolism among people aged younger than 75 years, according to a study published online Aug. 23 in the Annals ...
Aug 24, 2022
0
80
Many Americans know of the potential risks to themselves and their families from infection with COVID-19, but growing numbers say they have returned to living their "normal" pre-pandemic lives, according to July 2022 national ...
Aug 15, 2022
0
145
About 135 million more doses of Johnson & Johnson's COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday.
Aug 11, 2022
0
34
